Adrenergic Agents Flashcards
general principles for characterizing receptors and subtypes
block agonist effects by specific competitive agonists
potency (selectivity) sequences of agonists
molecular biology, cloning receptors and demonstrating different structural subtypes
EPI reversal
high doses of EPI with ergotoxin (alpha1 blocker) decreases blood pressure instead of increasing it
effects of alpha1 receptors
contraction of iris, bronchioles, vascular smooth muscle, splenic capsule, uterine smooth muscle, male sexual organs, pilomotor muscle, urinary bladder, gastrointestinal sphincters
effects of beta2 receptors
relaxation of bronchioles, vascular smooth muscle, splenic capsule, uterine smooth muscle, urinary bladder, and intestinal smooth muscle
effects of beta1 receptors
increase cardiac sinus rate, contractile force, and conduction
renin release in kidney
increases aqueous humor secretion
effects of alpha2 receptors
relaxation of intestinal smooth muscle
decrease in cardiac sinus rate
accumulation of fat
decrease in insulin secretion
decrease in aqueous humor secretion
contractile and secretory signal transduction motif
for alpha1 agonists
phospholipase C activation, fast enzymes
G protein stimulation, rapid increase in cytoplasmic Ca concentration
mediates CRAC channels aka store-operated calcium channels (SOCs) to open
amplifies contractile response
protein kinase A/cyclic AMP signal transduction motif
for beta agonists
slower, metabolic processes used by beta receptors
involves G protein-linked synthesis of cAMP and PKA phosphorylation
alpha2 receptor mechanism
G-protein mechanism that opens potassium channels and reduces excitability of cells
blocks calcium channels
inhibits adenylyl cyclase
direct effect on neurotransmitter release through the secretary apparatus
three prototype chatecholamines and their structure-activity releationships
norepinephrine - good stimulant of alpha and beta1, but no beta2
epinephrine - good stimulant of alpha, beta1, and beta2
isoproterenol - good stimulant of beta1 and beta2, but no alphas
non-cardiovascular effects of the prototypes
mydrasis - alpha potency
bronchiolar relaxation - beta2 potency
intestinal relaxation and glycogenolysis - produced by all types, EPI is the best
direct cardiovascular effects of the prototypes
heart rate increased by beta1 receptors, increased rate of diastolic depolarization by stimiulating pacemaker current If and Ca currents
force is augmented by increasing calcium entry from outside the cell and SR
most vascular beds have both alpha and beta2 receptors
three things to consider when looking at vascular bed effect of a catecholamine
selectivity of the drug
ratio of alpha to beta2 receptors
concentration of the drug
describe a cardiac action potential
sodium current
potassium opens at peak
L-type calcium channel maintains depolarization
delayed rectifiers restore the polarization
effect of norepinephrine on heartrate, blood pressure, and TPR
decrease TPR
increase in blood pressure
decreased heart rate
effect of epinephrine on heartrate, blood pressure, and TPR
decreas in TPR
small increase in blood pressure
increased pulse
effect of isoproterenol on heartrate, blood pressure, and TPR
decreased TPR
small decrease in pressure
increased heartrate
What happens when a high dose of EPI is administered to the heart?
increase and rate and force, leading to a great increase in systolic blood pressure
subsequent to this there is an increased diastolic pressure due to alpha vasoconstriction by the high EPI concentration
result is a rapid rise in mean blood pressure
therapeutic uses of prototypes
bronchodilator = beta 2
mydriatic = alpha
increased cardiac contractile force = beta1
vaso constrictor = alpha
contraindications of catecholamines
pressor effects - high bp, hyperthyroid problems
arrhytmias - hyperthyroid patients have more beta receptors
diabetes
narrow angle glaucoma
prostate enlargement
absorption, fate, and excretion of clinical prototypes
EPI - oral absorption satisfactory, but metabolized by MAO in gut and liver, little effect
NE - orally ineffective, poor absoprtion from subcutaneous injection site, usually given by IV infusion, quickly inactivated in the body
iSO - poor substrate for MAO due to N-isopropyl group so longer acting
selective alpha1 receptor agonists
phenylephrine
imidazoline derivatives
midodrine
physiologcially relevant alpha2 sites involved in the control of blood pressure
tonic firing of sympathetic nerves contribute to cardiac output via beta1 receptors and to the tonic constirction of blood vessels via alpha1 receptors
the activation of alpha2 receptors in the hypothalamus or the medulla inhibits this tonic sympathetic firing and relieves the tonic constriction of blood vessels, thus reducing blood pressure